Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles. The company also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations. As of March 21, 2019, it operated 43 dispensaries, 12 cultivation sites, and 11 processing sites. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone781-451-0150
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Curaleaf (OTCMKTS:CURLF) Frequently Asked Questions
What is Curaleaf's stock symbol?
Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF."
What price target have analysts set for CURLF?
7 analysts have issued 1-year price objectives for Curaleaf's stock. Their forecasts range from $5.00 to $11.00. On average, they anticipate Curaleaf's stock price to reach $7.96 in the next year. This suggests a possible upside of 29.1% from the stock's current price. View Analyst Price Targets for Curaleaf.
What is the consensus analysts' recommendation for Curaleaf?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Curaleaf.
Has Curaleaf been receiving favorable news coverage?
News coverage about CURLF stock has been trending negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Curaleaf earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Curaleaf.
Who are some of Curaleaf's key competitors?
Some companies that are related to Curaleaf include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).
What other stocks do shareholders of Curaleaf own?
Who are Curaleaf's key executives?
Curaleaf's management team includes the folowing people:
- Mr. Boris Alexis Jordan, Exec. Chairman (Age 53)
- Mr. Joseph Lusardi, Pres, CEO & Director (Age 44)
- Mr. Neil P. Davidson, Chief Financial Officer (Age 47)
- Mr. Stuart Anthony Wilcox, Chief Operating Officer (Age 58)
- Ms. Christine Rigby, Sr. VP of Investor Relations
How do I buy shares of Curaleaf?
Shares of CURLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Curaleaf's stock price today?
One share of CURLF stock can currently be purchased for approximately $6.17.
What is Curaleaf's official website?
How can I contact Curaleaf?
The company can be reached via phone at 781-451-0150.
MarketBeat Community Rating for Curaleaf (OTCMKTS CURLF)
MarketBeat's community ratings are surveys of what our community members think about Curaleaf and other stocks. Vote "Outperform" if you believe CURLF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CURLF will underperform the S&P 500 over the long term. You may vote once every thirty days.
